Chen Yan, Liu Jintao, Li Xiaofeng, Tang Dezhi, Jin Xiaoqin, Zhang Zhigang, Ji Wanbo, Tao Shuai, Jiang Hong
School of Rehabilitation Medicine, Henan University of Chinese Medicine, Zhengzhou 450046, China.
Suzhou Hospital of Traditional Chinese Medicine, 889 Wuzhongxi Road, Suzhou 215009, China.
Evid Based Complement Alternat Med. 2022 Feb 2;2022:4205648. doi: 10.1155/2022/4205648. eCollection 2022.
Golden plaster is the preferred and most commonly used in China for pain reduction in patients with knee osteoarthritis (OA). However, there was no evidence-based medical evidence about its effect in relieving pain of knee OA patients. Here, a multicenter randomized, double-blind, placebo-controlled trial was performed to evaluate the efficacy and safety of golden plaster for the improvement of pain relief and function's obstacle in patients with knee OA.
320 patients with knee OA were enrolled at four hospitals and randomly divided into the treatment group and the control group with 160 subjects in each group. Patients in treatment group were treated with golden plaster, and those in control group with placebo plaster. The study cycle in both groups was 21 days. Patient visits were documented before treatment and 7-, 14-, and 21-day follow-ups after treatment. The outcomes included VAS score, WOMAC score, and adverse events.
Compared to the control group, the VAS score in the treatment group was significantly decreased after treatment with golden plaster for 7 days, 14 days, and 21 days. Compared to the control group, the WOMAC score in the treatment group was significantly decreased 14 days and 21 days. The incidence rate of adverse events had no statistical difference between both the groups.
In conclusion, our study, for the first time by carrying on the double-blind and placebo-controlled randomized trial, showed that golden plaster can effectively alleviate the pain of knee and improve the physical function in the patients with knee OA. This trial is registered with ChiCTR-TRC-13003418.
金黄膏是中国治疗膝关节骨关节炎(OA)患者疼痛时的首选且最常用药物。然而,关于其缓解膝关节OA患者疼痛的效果,尚无循证医学证据。在此,我们进行了一项多中心随机、双盲、安慰剂对照试验,以评估金黄膏改善膝关节OA患者疼痛缓解及功能障碍的疗效和安全性。
四家医院招募了320例膝关节OA患者,随机分为治疗组和对照组,每组160例。治疗组患者使用金黄膏治疗,对照组患者使用安慰剂膏剂治疗。两组的研究周期均为21天。记录患者治疗前及治疗后7天、14天和21天的随访情况。观察指标包括视觉模拟评分(VAS)、西安大略和麦克马斯特大学骨关节炎指数(WOMAC)评分及不良事件。
与对照组相比,治疗组使用金黄膏治疗7天、14天和21天后,VAS评分显著降低。与对照组相比,治疗组在14天和21天时WOMAC评分显著降低。两组不良事件发生率无统计学差异。
总之,我们的研究首次通过双盲和安慰剂对照随机试验表明,金黄膏可有效缓解膝关节OA患者的疼痛并改善其身体功能。本试验在中国临床试验注册中心注册,注册号为ChiCTR-TRC-13003418。